Kresimir Pucaj

Title: Kresimir Pucaj: Innovator in Respiratory Treatment

Introduction

Kresimir Pucaj is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of respiratory medicine, particularly in the treatment of asthma and chronic obstructive pulmonary disease (COPD). With two patents to his name, Pucaj is recognized for his innovative approaches to improving patient care.

Latest Patents

Pucaj's latest patents focus on methods of treating asthma and COPD. These patents describe the administration of the non-steroidal anti-inflammatory drug norketotifen, which can be an isomer, an isomeric mixture, a prodrug, or a pharmaceutically acceptable salt. The methods aim to treat respiratory disorders in human patients without exposing them to adverse immune-suppressive effects. Notably, these methods include treating acute and potentially life-threatening exacerbations of COPD and asthma with norketotifen.

Career Highlights

Kresimir Pucaj is currently associated with Bridge Pharma Inc., where he continues to develop innovative treatments for respiratory conditions. His work has garnered attention for its potential to improve the quality of life for patients suffering from these chronic diseases.

Collaborations

Pucaj collaborates with esteemed colleagues, including Vincent B. Ciofalo and A.K. Gunnar Aberg. These partnerships enhance the research and development efforts at Bridge Pharma Inc., contributing to advancements in respiratory treatment.

Conclusion

Kresimir Pucaj is a dedicated inventor whose work in respiratory medicine is paving the way for new treatment options for asthma and COPD. His innovative patents and collaborations reflect his commitment to improving patient outcomes in this critical area of healthcare.